Symbion chief to take on expanded role with parent company.
EBOS Limited, the NZ company which acquired Symbion Healthcare last year, has just announced that Symbion chief Patrick Davies will become the head of the EBOS Group later this year.
It’s part of a series of succession planning moves which will also see EBOS chairman Rick Christie retire at the company’s annual general meeting in October 2015.
Longstanding EBOS MD and CEO Mark Waller will then take over the role of Chairman in 2015, after having retired from his managing director role at the conclusion of the group’s full year result presentations in August 2014. He’ll then “undertake a key project role for 12 months to work on driving the next phase of the EBOS growth story”.
Davies, who’s currently heads up Symbion, will become CEO of EBOS Group, while Symbion’s chief financial officer John Cullity will become the CFO of the overarching business.
EBOS this morning reported a net profit after tax of $49.4 million for the six months to 31 December, surpassing forecasts in its prospectus supporting the Symbion acquisition.
More information in today’s Pharmacy Daily.